Gestational diabetes not found to alter the metabolic processes in obese pregnant women

(June 22, 2004) - Bethesda, MD - Gestational diabetes is a type of diabetes, or high blood sugar, that only pregnant women get. If a woman is found to have high blood sugar when she's pregnant, but she never had high blood sugar before, she has gestational diabetes. Nearly 135,000 pregnant women get the condition every year, making it one of the top health concerns related to pregnancy.

The energy cost of pregnancy and amount of increased fat during pregnancy vary among women in different cultures. Consequently, recommendations for nutritional intake in pregnancy are diverse and depend on the study population, thereby making the development of general nutritional guidelines difficult.

Past studies have focused on long-term changes in energy expenditure and increase in fat in lean women (body fat less than 25 percent) with normal glucose tolerance (NGT) and gestational diabetes mellitus (GDM) relative to the alterations in carbohydrate metabolism during gestation.

However, similar data in obese women have not been reported. This is important to American women because the prevalence of obesity (defined as body mass index greater than 30) now approaches 20 percent in adolescents and adults, reaching epidemic proportions. Given the strong association of obesity with decreased insulin sensitivity, researchers prospectively evaluated changes, over an extended time period, in energy expenditure and increase in fat in a cohort of women with NGT and GDM, relative to the alterations in insulin sensitivity during gestation.

A New Study

A team of researchers has hypothesized that women with decreased pre-pregnancy insulin sensitivity, i.e. the GDM subjects, have a decrease in energy expenditure and an increase in fat accretion as compared with a matched NGT group. Additionally, because the role of the increased maternal serum leptin (a helical protein secreted by adipose tissue and acting on a receptor site in the ventromedial

Contact: Mayer Resnick
American Physiological Society

Page: 1 2 3 4 5

Related biology news :

1. Joslin Diabetes Center honors brothers living 70-plus years with type 1 diabetes
2. New fruitfly model of diabetes has future implications for pancreatic cell transplantation
3. A probable cause for high blood pressure identified - shows links with diabetes
4. Joslin President awarded medal from international diabetes organization
5. New imaging technology at Joslin shown to detect early signs of type 1 diabetes
6. Protemix corporation announces discovery of way to repair hearts damaged by diabetes
7. Genetic mutation found that is major contributor to type 1 diabetes
8. Joslin researchers identify key molecule in Type 1 diabetes progression
9. Lab mice rescued from Type 1 diabetes via dendritic cell-assisted therapy
10. Study links diabetes and colorectal cancer
11. Cinnamon may help to alleviate diabetes says UCSB researcher

Post Your Comments:

(Date:11/12/2015)... golden retriever that stayed healthy despite having the gene ... new lead for treating this muscle-wasting disorder, report scientists ... and Harvard and the University of São Paolo in ... pinpoints a protective gene that boosts muscle regeneration, ... Children,s lab of Lou Kunkel , PhD, is ...
(Date:11/10/2015)... Nov. 10, 2015 About ... that helps to identify and verify the identity ... considered as the secure and accurate method of ... a particular individual because each individual,s signature is ... especially when dynamic signature of an individual is ...
(Date:10/29/2015)... Oct. 29, 2015   MedNet Solutions , an ... spectrum of clinical research, is pleased to announce that ... Association (MHTA) as one of only three finalists for ... – Small and Growing" category. The Tekne Awards honor ... shown superior technology innovation and leadership. ...
Breaking Biology News(10 mins):
(Date:11/24/2015)... LUMPUR, Malaysia , Nov. 24, 2015 /PRNewswire/ ... global contract research organisation (CRO) market. The trend ... result in lower margins but higher volume share ... increased capacity and scale, however, margins in the ... Research Organisation (CRO) Market ( http://www.frost.com/sublib/display-report.do?id=P86A-01-00-00-00&src=PR ), ...
(Date:11/24/2015)... 2015 Halozyme Therapeutics, Inc. (NASDAQ: HALO ) will ... New York on Wednesday, December 2 at 9:30 a.m. ... and CEO, will provide a corporate overview. th ... at 1:00 p.m. ET/10:00 a.m. PT . Jim Mazzola ... a corporate overview. --> th Annual Oppenheimer Healthcare ...
(Date:11/24/2015)... ... November 24, 2015 , ... ... the year and one of the premier annual events for pharmaceutical manufacturing: 2015 ... 8–11 November 2015, where ISPE hosted the largest number of attendees in more ...
(Date:11/24/2015)... 2015 --> ... "Oligonucleotide Synthesis Market by Product & Services (Primer, Probe, ... DNA, RNAi), End-User (Research, Pharmaceutical & Biotech, Diagnostic Labs) ... market is expected to reach USD 1,918.6 Million by ... CAGR of 10.1% during the forecast period. ...
Breaking Biology Technology:
Cached News: